Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

0.6927
Delayed Data
As of Feb 11
 -0.0372 / -5.10%
Today’s Change
0.52
Today|||52-Week Range
3.92
-32.75%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close0.73
Today’s open0.72
Day’s range0.66 - 0.72
Volume89,416
Average volume (3 months)320,244
Market cap$67.0M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)+3.70%
Earnings growth (this year)+5.77%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.88%
P/E ratioNM
Price/Sales12,577.60
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
TENXTenax Therapeutics I...+0.02+0.86%
PSTIPluristem Therapeuti...-0.01-0.63%
PIRSPieris Pharmaceutica...-0.05-3.21%
PLXProtalix Biotherapeu...-0.01-1.30%
Data as of 02/11/2016

Financials

Next reporting dateMarch 16, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$18.8K
Annual profit (last year)-$22.6M
Net profit margin-120,154.75%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientific Officer
Karl Y. Johe
President, CEO, Director &
Legal Counsel
I. Richard Garr
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers